WKHS Locations

Clinical Trials

NSABP-B-34

Study Title

NSABP-B-34

Purpose

This is a clinical trial comparing adjuvant clodronate therapy vs placebo in early stage breast cancer patients receiving chemotherapy and/or hormonal therapy.

Eligibility

Contact Principal Investigator for Information

Study Process

Contact Principal Investigator for Information

Trial Details

Principal Investigator:

Robert Nickelson, M.D.

IRB:

Willis-Knighton

IRB Number:

02.0271

Trial Type:

Device

Sponsor:

NSABP

Contact Information:

Hematology Oncology Associates
(318) 212-3702
http://cancer.wkhs.com